ANI Pharmaceuticals gets FDA approval for generic everolimus suspension
ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) announced it received final approval from the U.S. Food and Drug Administration for its Abbreviated ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)

